Cargando…
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
Autores principales: | Tleyjeh, Imad M., Kashour, Tarek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799422/ https://www.ncbi.nlm.nih.gov/pubmed/33432434 http://dx.doi.org/10.1007/s11606-020-06369-x |
Ejemplares similares
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021) -
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Kashour, Zakariya, et al.
Publicado: (2021) -
It is time to drop hydroxychloroquine from our COVID-19 armamentarium
por: Kashour, Tarek, et al.
Publicado: (2020) -
Letter to the Editor Regarding ‘“Staying Home”—Early Changes in Patterns of Neurotrauma in New York City during the COVID-19 Pandemic’
por: Agrawal, Amit, et al.
Publicado: (2020) -
Letter to the Editor Regarding “‘Staying Home’—Early Changes in Patterns of Neurotrauma in New York City During the COVID-19 Pandemic”
por: Goyal, Nishant, et al.
Publicado: (2021)